约翰逊和约翰逊看到投资者动向不同, 但报告强的收益, 获得"中等买入"评级. Johnson & Johnson saw varied investor moves but reported strong earnings, earning a "Moderate Buy" rating.

Johnson & Johnson(JNJ)在第四季度看到混合机构投资者活动。 Johnson & Johnson (JNJ) saw mixed institutional investor activity in the fourth quarter. 冷流资本管理公司持有量增加了0.5%,而约翰逊金融集团的股份减少了4.4%。 Coldstream Capital Management increased its holdings by 0.5%, while Johnson Financial Group reduced its stake by 4.4%. JNJ报告收入丰厚,粗略估算为0.18美元,分析家预测“机动购买”,价格目标是171.82美元。 JNJ reported strong earnings, beating estimates by $0.18, and analysts predict a "Moderate Buy" with a price target of $171.82. 该公司的股票有3.36%的股息收益,通过创新医药和医疗技术部分在保健领域开展业务。 The company's stock has a 3.36% dividend yield and operates in healthcare through Innovative Medicine and MedTech segments.